Developers: | DePuy Synthes |
Date of the premiere of the system: | May 2022 |
Branches: | Pharmaceuticals, medicine, healthcare, Manufacturers of medical devices |
Content |
History
2022: System Release
On May 17, 2022, DePuy Synthes, a specialist in the production of orthopedic devices, a member of the Johnson & Johnson group, announced the launch of the first fully transformable endoprosthesis system for total shoulder arthroplasty - Inhance.
Representatives of DePuy Synthes state that their company is the first to market technology that is an addition to the already authorized use of the system for anatomical arthroplasty of the shoulder joint and provides surgeons with flexibility in performing operations.
Features of the reversing system include:
- Shaft journal angle 135 ° with possibility of lateralization;
- Variety of size options;
- 3D laser printing of R/SPEED base plates and modular base plates with center screw and center pin;
- Advanced cross-linked vitamin E polyethylene to provide the required wear and oxidative stability characteristics;
- One Step Prep Glenoid Expanders.
{{quote 'The Inhance shoulder system can be used for anatomical or reverse shoulder procedures, offering the surgeon and operating room staff a simplified and effective shoulder system. This system contains the necessary tools from preoperative planning to intraoperative flexibility with two tool trays to ensure a stable outcome, said Andrew Jawa, an orthopedic surgeon at New England Baptist Hospital. }} Arthroplasty is a method of surgery, the purpose of which is to promptly restore the anatomical structures and functions of damaged joints. In the process of arthroplasty, there is an operational assessment of damage to the structures of the articular components, restoration of the latter with the creation of favorable conditions for the restoration or replacement of the articular cartilage with the tissues of the patient himself or artificial materials.[1]